| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| LXRX LEXICON PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 19,893 | — | — | 92,532 | Apr 22, 2020 | Apr 24, 2020 ↗ | View → |
| LXRX LEXICON PHARMACEUTICALS, INC. | SALE EVP and CMO | 6,813 | $1.96 | $13.4K | 85,719 | Apr 22, 2020 | Apr 24, 2020 ↗ | View → |
| LXRX LEXICON PHARMACEUTICALS, INC. | SALE EVP and CMO | 8,570 | — | — | 8,570 | Feb 28, 2020 | Mar 3, 2020 ↗ | View → |
| LXRX LEXICON PHARMACEUTICALS, INC. | PURCHASE EVP and CMO | 4,228 | — | — | 51,326 | Feb 28, 2020 | Mar 3, 2020 ↗ | View → |
| LXRX LEXICON PHARMACEUTICALS, INC. | SALE EVP and CMO | 2,585 | — | — | 2,585 | Feb 28, 2020 | Mar 3, 2020 ↗ | View → |
| LXRX LEXICON PHARMACEUTICALS, INC. | PURCHASE EVP and CMO | 2,585 | — | — | 53,911 | Feb 28, 2020 | Mar 3, 2020 ↗ | View → |
| LXRX LEXICON PHARMACEUTICALS, INC. | SALE EVP and CMO | 4,228 | — | — | 0 | Feb 28, 2020 | Mar 3, 2020 ↗ | View → |
| LXRX LEXICON PHARMACEUTICALS, INC. | PURCHASE EVP and CMO | 23,463 | — | — | 85,944 | Feb 28, 2020 | Mar 3, 2020 ↗ | View → |
| LXRX LEXICON PHARMACEUTICALS, INC. | SALE EVP and CMO | 13,305 | $2.77 | $36.9K | 72,639 | Feb 28, 2020 | Mar 3, 2020 ↗ | View → |
| LXRX LEXICON PHARMACEUTICALS, INC. | PURCHASE EVP and CMO | 8,570 | — | — | 62,481 | Feb 28, 2020 | Mar 3, 2020 ↗ | View → |
| LXRX LEXICON PHARMACEUTICALS, INC. | SALE EVP and CMO | 23,463 | — | — | 46,927 | Feb 28, 2020 | Mar 3, 2020 ↗ | View → |
| LXRX LEXICON PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 247,220 | — | — | 247,220 | Feb 6, 2020 | Feb 10, 2020 ↗ | View → |
| LXRX LEXICON PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 82,410 | — | — | 82,410 | Feb 6, 2020 | Feb 10, 2020 ↗ | View → |